About: Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
Creator	Dong, Hui Cao, Song Chen, Erzhen Li, Qingyun Tong, Hospital, Shanghai Fu, Shouzhi Yang, Luyu Cao2, Song Chen4, Erzhen Li3, Qingyun Shanghai, Ruijin Wang, Ruilan Wang1, Ruilan Xie, Yun Zhang, Wenkai Zhang2, Wenkai
Source	Elsevier; Medline; PMC
abstract	• Initiation of IVIG as adjuvant treatment for COVID-19 pneumonia within 48 hours of admission to the ICU can reduce the use of mechanical ventilation . • Initiation of IVIG as adjuvant treatment for COVID-19 pneumonia within 48 hours of admission to the ICU can reduce hospital length of stay and length of stay in ICU. • Initiation of IVIG as adjuvant treatment for COVID-19 pneumonia within 48 hours of admission to the ICU can reduce 28-day mortality of patients with severe COVID-19 pneumonia.
has issue date	2020-04-10(xsd:dateTime)
bibo:doi	10.1016/j.jinf.2020.03.044
bibo:pmid	32283154
has license	els-covid
sha1sum (hex)	66f9d7bbd5da0c1dd7d11caa05610f1c0dc0f447
schema:url	https://doi.org/10.1016/j.jinf.2020.03.044
resource representing a document's title	Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
has PubMed Central identifier	PMC7151471
has PubMed identifier	32283154
schema:publication	J Infect
resource representing a document's body	covid:66f9d7bbd5da0c1dd7d11caa05610f1c0dc0f447#body_text
is schema:about of	named entity 'adjuvant treatment' covid:arg/66f9d7bbd5da0c1dd7d11caa05610f1c0dc0f447 named entity 'Highlights' named entity 'ICU' named entity 'adjuvant treatment' named entity 'ICU' named entity 'IVIG' named entity 'IVIG' named entity 'ICU' named entity 'length of stay' named entity 'infection' named entity 'viral load' named entity 'MERS' named entity 'pneumonia' named entity 'inflammatory' named entity 'ventilator' named entity 'COVID' named entity 'IVIG' named entity 'virus' named entity 'health care workers' named entity 'COVID' named entity 'Japan' named entity 'informed consent' named entity 'IgG' named entity 'oxygen' named entity 'intravenous administration' named entity 'Wuhan' named entity 'pathogen' named entity 'prognosis' named entity 'IVIG' named entity 'critically ill patients' named entity 'randomized controlled studies' named entity 'white blood cells' named entity 'Continuous infusion' named entity 'IVIG' named entity 'ethics committee' named entity 'IVIG' named entity 'IVIG' named entity 'protein' named entity 'symptoms and signs' named entity 'IVIG' named entity 'pneumonia' named entity 'COVID' named entity 'IVIG' named entity 'prognosis' named entity 'mechanical ventilation' named entity 'H1N1 infection' named entity 'COVID' named entity 'coronavirus' named entity 'COVID' named entity 'COVID' named entity 'pneumonia' named entity 'pneumonia' named entity 'intravenous immunoglobulin' named entity '28 days' named entity 'epidemiological' named entity 'IVIG therapy' named entity 'COVID-19' named entity 'IVIG' named entity 'Italy' named entity 'sample size' named entity 'vaccine' named entity 'real-time RT-PCR' named entity 'antiviral treatment' named entity 'infection'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software